



Objective: To identify carotid stenosis (CS) prevalence and potential mortality predic-
tors in individuals undergoing elective coronary artery bypass grafting (CABG). Meth-
ods: Cohort study including 393 scheduled for CABG. All patients underwent a color 
Doppler ultrasound study of the carotid arteries prior to CABG and were assessed for 
morbidity and mortality over the hospitalization. CS was considered clinically relevant 
when if ≥ 50%. Significance was set at p < 0.05. Logistic regression was used to define 
mortality independent predictors. Results: CS prevalence was 17.4%. Following logistic 
regression analysis, CS ≥ 50% (p = 0.001) and chronic renal failure (CRF) (p = 0.03) re-
mained as mortality independent predictors. Conclusion: CS showed a high prevalence 
in the study sample and together with CRF was a mortality independent factor.
Keywords: Carotid arteries; atherosclerosis; coronary artery disease; coronary artery 
bypass grafting.
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INTRODUCTION
Significant disease in the carotid artery causes a four-fold 
increase in stroke perioperative risk1.  e identification of 
a carotid stenosis (CS) previously to a carotid artery bypass 
graft (CABG surgery can change the surgical management 
and reduce morbidity from stroke2,3 and mortality with ac-
ceptable risks and cost4,5. To date, information is still insu -
cient to declare carotid endarterectomy previously or simul-
taneously with CABG is superior in patients with coronary 
artery disease (CAD) to prevent a postoperative CABG6-12.
Carotid ultrasound has been considered an eective 
and widely accepted screen tool for carotid disease exami-
nation, being conducted rapidly and safely13.
In view of the lack of data about the matter, the current 
study aimed to evaluate by color Doppler carotid ultra-
sound the CS prevalence in patients who will undergo an 
elective CABG. Secondarily, the ultrasound can identify 
associated factors that could be death predictors postop-
eratively over the hospitalization period.
METHODS
 is is a contemporary cohort study of 393 consecutive 
patients admitted to the Institute of Cardiology of Rio 
Grande do Sul to undergo a CABG and invited to partici-
pate in a CS screen preoperatively.  e primary endpoint 
was death.
All patients signed an informed consent and the study 
was approved by the Institute Research Ethics Committee. 
 e data collection was started in May 2007 and closed in 
April 2008.
SAMPLE SIZE CALCULATION
Considering a beta error 20% and an expected CS frequen-
cy 6.3%, 393 individuals would be required to reach the 
statistical di  erence (p  <  0.05) concerning the mortality 
independent predictors.
PATIENTS
  e specific criteria for surgery indication were observed14.
Patients who did not agree to participate in the study 
or those with a concomitant surgery indication (CABG 
and carotid endarterectomy) were excluded.
STUDY PROCEEDINGS
All patients underwent a color Doppler ultrasound of the 
carotid arteries.
COLOR DOPPLER ULTRASOUND
  e ultrasound studies were carried out by three physi-
cians specialized in vascular ultrasonography, blinded to 
any patient’s clinical history or physical examination data 
and who adopted the same criteria to diagnose CS in an ul-
trasound apparatus (GE Logiq 500; General Electric Medi-
cal Systems, Milwaukee, WI).
  e stenosis was identified and rated by the following 
parameters: linear stenosis and stenosis area.
STATISTICAL ANALYSIS
Continuous variables were expressed as mean ± standard 
deviation (SD) and compared by the two-sided Student’s 
t test.   e two-sided Mann-Whitney U test was used for 
variables with non-normal distribution. Qualitative vari-
ables were expressed as numbers and percentage.   e me-
dian was used for variables with non-normal distribution.
Either the chi-squared or the Fisher’s exact test was 
used to compare categorical variables in univariate analy-
sis: patients without CS or CAD versus patients with coex-
isting CS and CAD.
  e odds ratio (OR) and its 95% confidence inter-
val (CI) were calculated for each risk factor, with a cor-
responding p-value, thus determining correlation limits 
with a 5% error.
Baseline di  erences across the groups regarding demo-
graphic variables were determined by multivariable anal-
ysis in order to evaluate which independent risk factors 
were associated with CS and CAD.
  e variables selected by univariate analysis with 
p    0.20 underwent multivariate analysis by using the lo-
gistic regression method to determine death independent 
predictors.
A p-value < 0.05 was considered significant.
RESULTS
In the 393 patients included in the study, the patients’ mean 
age (± SD) was 62.4 ± 9.4 (ranging from 38 to 85 years); 
out of them, 65.3% (257) were male and 94.1% (370) were 
Caucasian. Clinical characteristics and the sample baseline 
comorbidities, separated by the presence of CS, are listed 
in Table 1.
All surgeries were performed with cardiopulmonary 
bypass and elective.   ere were concomitant procedures 
in 12.7% (50). Transoperative complications were seen in 
2.5% (10) of cases.
  e main postoperative complications were: cardio-
genic shock in 0.7% (3), vasopressor use for more than 
48 hours in 4.0% (16), mechanical ventilation for over 48 
hours in 3.5% (14), sepsis in 2.2% (9), respiratory infection 
in 3.8% (15), and urinary tract infection in 1.2% (5).
CS prevalence ≥ 50% was 17.4% (76) of the total study 
patients. Out of these, 12.0% (47) of patients had CS be-
tween 50 and 69% and 7.4% (29), CS ≥ 70%.
Medical and family history had the following distribu-
tion: cardiovascular disease (CVD) family history in 81.7% 
(321), left coronary trunk (LCT) stenosis in 34.4% (135), 
obesity in 32.1% (126), diabetes mellitus in 28.4% (112), 
peripheral obstructive arterial disease (POAD) in 23.4% 
(92), chronic obstructive pulmonary disease (COPD) in 
12.4% (71) and CRF in 6.9% (27). Although di  erences 
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Tabela 1 – Clinical characteristics and baseline comorbidities regarding the carotid stenosis degree
Stenosis degree
Clinical endpoint  50 % < 50 % OR p 95% CI
Psychomotor agitation 4 8.2 4 2.1 4.2 0.03 1.1-15.3
TIA 2 4.3 0 - 0.1 0.04 0.1-0.2
Cognitive change 8 16.7 10 5.2 3.5 0.01 1.3-9.5
Stroke - 1.7% 3 4.3 4 2.1 0.3 0.15 0.07-1.5
Death - 8.1% 14 17.4 18 5.7 3.7 0.001 1.7-7.9
OR, odds ratio; CI, confidence interval; TIA, transient ischemic attack
Table 2 – Occurrence of neurologic endpoints and mortality over stenosis carotid degree
across many variables concerning the CS degree have been 
observed, they were not shown statistically significant, ex-
cept for the physical examination finding of a carotid mur-
mur (p < 0.001).
Considering the CS degree: 77.1% (303) of the pa-
tients had a stenosis <  50%, 12.0% (47) had a stenosis 
between 50% and 69%, 7.1% (28) had a stenosis between 
70% and 99%, and 0.3% (1) had an internal carotid artery 
(ICA occlusion.  e examination was normal in 3.6% 
(14) of the sample. Regarding the gender, 67.1% (51) of 
patients with a stenosis ≥ 50% were male.
 e carotid murmur was detected in 35.5% (27) of the 
patients with CS and in 10.4% (33) of those with CS lower 
than 50%.  e odds ratio (OR) for patients with a carotid 
murmur was 3.8 times (95% CI = 2.32-8.47; p < 0.0001) 
as high for significant CS.
 e overall mortality was 8.1% (32) and 17.4% 
(p = 0.001) of patients had CS ≥ 50%.
In univariate analysis, the OR for neurological endpoints 
and mortality for a SC degree ≥ 50% was 4.2 (95% CI = 1.1-
15.3) for psychomotor agitation; 0.3 (95% CI = 0.07-1.5) for 
stroke and 3.7 (95% CI = 1.7-7.9) for death (Table 2).
No predictors for stroke occurrence were identified 
in univariate analysis; for mortality, the predictors were 
as follows: CS ≥ 50% (OR = 3.7; p = 0.001, 95% CI = 1.7-
7.9); CRF (OR = 0.3; p = 0.05, 95% CI = 0.1-0.9); obesity 
(OR = 2.1; p = 0.11; 95% CI = 0.8-5.3); and low physical 
activity (OR = 0.4; p = 0.16; 95% CI: 0.7-8.1).
After multivariate analysis, CS  ≥  50 (OR  =  12.3; 
p = 0.001; 95% CI = 1.6-7.6) and CRF (OR = 3.7; p = 0.03; 




50% (n=76) <50% (n=317) p
Age (years±SD) 62.5 ± 7.9 62.3 ± 9.7 0.88
Gender male 67.1 65.9 0.89
Caucasian ethnicity 96.1 93.4 0.81
Carotid murmur 35.5 10.4 < 0.0001
Risk factors: n (%)
Systemic arterial hypertension 81.6 84.2 0.60
Diabetes 28.9 28.3 0.88
Smoking 17.1 18.0 1.00
Obesity (BMI ≥ 30 kg/m²) 80.3 65.0 0.01
BMI (kg/m² ± SD) 27.2 ± 3.3 28.1 ± 4.4 0.04
Waist circumference (cm±SD) 91.2±10.8 94.9±12.5 0.12
CVD family history 78.1 82.0 036
Low physical activity 80.3 81.1 0.87
Dyslipidemia 31.6 25.9 0.31
Comorbidities
Peripheral obstructive arterial disease 23.7 23.3 1.00
LCT lesion 73.7 63.7 0.10
CRF (creatinine ≥1.5 mg/dL) 6.6 6.9 0.57
Chronic obstructive pulmonary disease 15.6 11.4 0.31
SD, standard deviation; BMI, body mass index; CVD, cardiovascular disease; LCT, left coronary trunk; CRF, chronic renal failure
MARCELO PEREIRA DA ROSA ET AL.
320 Rev Assoc Med Bras 2011; 57(3):317-321
Variable OR 95% CI p
Carotid stenosis ≥50% 12.3 1.6-7.6 0.001
Chronic renal failure 3.7 1.0-9.6 0.03
Obesity 1.9 0.2-1.3 0.17
Low physical activity 1.8 0.7-8.3 0.15
CABG, coronary artery bypass grafting; OR, odds ratio; CI, confi-
dence interval. Controlled variables: age, diabetes, systemic arterial 
hypertension, low physical activity, obesity, cardiovascular disease 
family history, peripheral obstructive arterial disease, and smoking.
Table 3 – Mortality independent predictors in patients with 
a CABG indication
DISCUSSION
CS had a high prevalence (17.4%) and was a mortality 
independent predictor together with CRF in 393 patients 
with CAD undergoing elective CABG. CS prevalence was 
high if compared with other studies involving patients 
with DAC in which the rate was 6% to 15%.  is value is 
higher than that expected perhaps because it was a higher 
risk population seen in a tertiary cardiology center where 
high complexity cases are referred to receive care15-18.
Another major aspect demonstrated was that patients 
with a carotid murmur had a risk 3.8 times as high to be 
found with a CS, stressing the physical examination im-
portance, although sensitivity for carotid murmur diagno-
sis has been low (34%).  e carotid murmur is the most 
available physical examination data in clinical practice, 
although it has an important limitation: according to the 
NASCET study19, a carotid murmur had a sensitivity 63% 
and a specificity 61%.  e authors concluded it should not 
be overestimated because of its low specificity and as the 
sensitivity is low, the murmur will not be found in up to 
one-third of patients with CS ≥ 70%.
Regarding risk factors for carotid disease in patients 
with severe coronary disease, we found no statistically sig-
nificant dierence for gender, age, smoking status, dyslip-
idemia, hypertension, acute myocardial infarction (AMI) 
and/or stroke.
 e screening, in turn, can also be helpful in the diag-
nosis and follow-up in cases with conservative treatment 
indication because CS, per se, is a risk marker, especially 
for vascular death.  e presence of CS can change the 
surgical management with acceptable risks and cost, with 
these being similar both in concomitant surgeries and ca-
rotid revascularization with subsequent CABG, even in 
asymptomatic patients.
We believe the CS investigation by ultrasound is valid 
in all patients possibly undergoing CABG, in agreement 
with Fukuda et al.2. If a CS is found, a CABG should be 
scheduled for a concomitant treatment with the carotid 
disease or for a further treatment.
Carotid ultrasound was the study chosen by us, as it is 
a non-invasive subsidiary method generally employed in 
screening carotid atherosclerotic disease. It has sensitivity 
and specificity similar to that of angiography20.  e latter 
is carrying on as the standard method and golden standard 
for cerebrovascular assessment in symptomatic people, 
but because of its high cost, and risk for stroke and other 
complications21, the exclusive use of non-invasive studies 
has been advocated.
By comparing patients with a preserved renal function 
at the carotid surgery, those with renal failure have simi-
lar stroke and perioperative death rates, but higher rates of 
heart events22. Renal dysfunction is significantly associated 
with increased mortality and morbidity following CABG 
and requires careful consideration regarding the risk-ben-
efit binomial when the surgery is indicated23.
CRF is associated with an increased atherosclerosis risk 
in these patients, but CABG oers more benefits for severe 
CAD patients than only drug therapy. Recent evidence sug-
gests internal mammary use in this surgery is especially 
better for those on hemodialysis24 without DM25. Moreover, 
long-term survival of patients with a satisfactory course 
over the postoperative hospital period is favorable26.
 e pursuit for reduced morbidity, mortality, and cost 
should include the part concerning the investigation27. 
 us, the eorts for a judicious use of diagnostic methods 
and the consequent reduction of cost and resulting compli-
cations would contribute to a more satisfactory treatment28.
CONCLUSION
CS prevalence was high in our study, suggesting we had a 
high-risk population that can benefit from a previous di-
agnosis of the disease. Also CS and CRF were independent 
predictors of postoperative death in patients undergoing 
elective CABG.
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